Clearside Biomedical Announces License Agreement with Aura Biosciences for Suprachoroidal Space Microinjector™ Designed to Optimize Ocular Oncology Drug Delivery July 9, 2019 - NASDAQ Companies 0 » View More News for July 09, 2019